Britain's Amryt Pharma raises profile with Nasdaq listing

·

·

Britain's Amryt Pharma raises profile with Nasdaq listing

LONDON, July 8 (Reuters) – Amryt Pharma , a rare disease specialist listed on London’s AIM and Dublin’s ESM markets, debuted on Nasdaq on Wednesday in a move aimed at increasing the liquidity of its stock and gaining more analyst coverage.
See Original Article

Biogen Stock Is Jumping. The Biotech Submitted Its Troubled Alzheimer's Drug for FDA Approval.

Not so long ago, the saga of Biogen’s experimental Alzheimer’s therapy aducanumab was, perhaps, the biggest story in biotech. Covid-19 changed all that, driving investor focus to the race for a vaccine. But Biogen is still moving forward with aducanumab, …
See Original Article

Perfect Day expands Series C to $300m; significantly boosts efficiency of animal-free dairy protein production

Perfect Day, a startup producing milk proteins via microbial fermentation (minus the cows), has expanded its Series C round from a previously-announced $140m, up to $300m through a new tranche led by CPP Investments and bolstered by long-time …
See Original Article

1st of 3 Massachusetts casinos reopens to gamblers

BOSTON (AP) — Plainridge Park Casino reopened on Wednesday, the first of Massachusetts’ three casinos to start accepting wagers again under the third phase of Gov. Charlie Baker’s coronavirus economic recovery plan. The slots parlor in Plainville has …
See Original Article

Bloomberg: Ascena preps bankruptcy plan that would close 1200 stores

Ascena Retail Group is preparing to file for Chapter 11 bankruptcy as soon as this week, according to a Bloomberg report that cited anonymous sources. Ascena did not immediately reply to Retail Dive’s request for comment. The apparel retailer plans to close …
See Original Article



Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.